The National Cancer Institute (NCI)-designated University of Kentucky (UK) Markey Cancer Center (MCC) defines its catchment area as the Commonwealth of Kentucky, with a special focus on the underserved communities of Appalachian Kentucky. There is no greater need for a Comprehensive NCI Cancer Center than in Kentucky, which is recognized for the highest overall cancer incidence and mortality rates in the United States, significantly elevated rates of cancer risk factors such as tobacco use and obesity, and severe socioeconomic disparities. The MCC has been at the forefront of combatting cancer and its related disparities in Kentucky for over 40 years through innovative cancer research, clinical care, and community outreach. Led by Dr. Robin Vanderpool (CP), Director of MCC Community Outreach and Engagement, MCC?s community outreach and engagement infrastructure includes: the MCC Network, consisting of the MCC Research Network (MCCRN, 6 community sites) and MCC Affiliate Network (MCCAN, 18 community hospitals); the developing Behavioral and Community-Based Research Shared Resource Facility (BCBR SRF); the Kentucky Cancer Registry; multiple cancer center and state outreach programs; well-aligned MCC cancer research projects; UK?s rurally placed health care, professional education, and community resources; and other vested local, state, national, and international stakeholders. Utilizing this unique infrastructure and diverse network of partners as well as data- and context-driven approaches to working with communities, MCC has an extensive portfolio of innovative and impactful projects focused on effective cancer control practices and health policy recommendations that have reached thousands of Kentucky residents and health care professionals. With continued CCSG funding, the MCC is well positioned to use this remarkable and expanding infrastructure to impact cancer within and beyond Kentucky and respond to emerging public health issues. The MCC?s overarching goal for community outreach and engagement is to accelerate science-to-practice translation across the cancer care continuum by leveraging and expanding its outreach and engagement infrastructure and network of partners within and beyond the Commonwealth of Kentucky.
Specific Aims are: (1) to enhance the MCC?s ability to define and characterize its catchment area using cancer surveillance data, cancer registry and health insurance data linkages, and locally derived population health assessment data; (2) to increase dissemination and implementation of evidence-based clinical practices and cancer control programming within and beyond MCC?s catchment area; and (3) to enrich bidirectional relationships and structures for conducting community outreach and engagement within and beyond MCC?s catchment area. In achieving these aims, MCC is solidly positioned to enhance and expand its existing community outreach and engagement initiatives over the next 5-year CCSG funding period to further reduce Kentucky?s significant cancer burden and improve quality of life among all Kentuckians.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA177558-07
Application #
9741651
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
7
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Kentucky
Department
Type
DUNS #
939017877
City
Lexington
State
KY
Country
United States
Zip Code
40526
Hubbard, W Brad; Harwood, Christopher L; Geisler, John G et al. (2018) Mitochondrial uncoupling prodrug improves tissue sparing, cognitive outcome, and mitochondrial bioenergetics after traumatic brain injury in male mice. J Neurosci Res 96:1677-1688
Alghamedy, Fatemah; Bopaiah, Jeevith; Jones, Derek et al. (2018) Incorporating Protein Dynamics Through Ensemble Docking in Machine Learning Models to Predict Drug Binding. AMIA Jt Summits Transl Sci Proc 2017:26-34
Wen, Yang-An; Xiong, Xiaopeng; Zaytseva, Yekaterina Y et al. (2018) Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer. Cell Death Dis 9:265
Zhang, Hui; Fredericks, Tricia; Xiong, Gaofeng et al. (2018) Membrane associated collagen XIII promotes cancer metastasis and enhances anoikis resistance. Breast Cancer Res 20:116
Zhong, Weixiong; Weiss, Heidi L; Jayswal, Rani D et al. (2018) Extracellular redox state shift: A novel approach to target prostate cancer invasion. Free Radic Biol Med 117:99-109
Xiong, Gaofeng; Stewart, Rachel L; Chen, Jie et al. (2018) Collagen prolyl 4-hydroxylase 1 is essential for HIF-1? stabilization and TNBC chemoresistance. Nat Commun 9:4456
Liu, Xinan; Yu, Ye; Liu, Jinpeng et al. (2018) A novel data structure to support ultra-fast taxonomic classification of metagenomic sequences with k-mer signatures. Bioinformatics 34:171-178
Al-Darraji, Ahmed; Haydar, Dalia; Chelvarajan, Lakshman et al. (2018) Azithromycin therapy reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction: Potential therapeutic targets in ischemic heart disease. PLoS One 13:e0200474
Jarrett, Stuart G; Carter, Katharine M; Bautista, Robert-Marlo et al. (2018) Sirtuin 1-mediated deacetylation of XPA DNA repair protein enhances its interaction with ATR protein and promotes cAMP-induced DNA repair of UV damage. J Biol Chem 293:19025-19037
Zaytseva, Yekaterina Y; Rychahou, Piotr G; Le, Anh-Thu et al. (2018) Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer. Oncotarget 9:24787-24800

Showing the most recent 10 out of 359 publications